Fig. 3From: Management of retinitis pigmentosa by Wharton’s jelly-derived mesenchymal stem cells: prospective analysis of 1-year resultsImprovement in “outer retinal thickness” according to study timepoints (T0, T1, T2) in the eye treated with WJ-MSCs (Table 1, patient 4: left eye—published data: a and b are the first 6-month changes of a patient from our previous study [46]). a Before application, 118.2 μm. b At 6th month, 145.4 μm. c At 12th month, 145.6 μmBack to article page